Explore 3 Stock Ideas & Industry Insights Download Free Report

News

DR REDDYS LABORATORIES (NYSE: RDY) Issues 375 Shares Under Employee Options

DR REDDYS LABORATORIES LTD (NYSE: RDY) allotted 375 fully paid equity shares on September 10, 2026, following eligible employee exercises under its stock option programme. The shares rank equally with existing equity.

Vinay Lochav | 11 September 2026

Elevance Health Reaffirms 2026 Earnings Guidance at $20.10 (NYSE: ELV)

Elevance Health, Inc. (NYSE: ELV) is reaffirming full-year 2026 shareholders’ earnings guidance of at least $20.10 per diluted share.

Vinay Lochav | 11 September 2026

Exelixis (NASDAQ: EXEL) Zanzalintinib FDA Action Date Set for March 3, 2027

EXELIXIS, INC. (NASDAQ: EXEL) said the FDA extended its review of zanzalintinib with atezolizumab for metastatic colorectal cancer by three months.

Vinay Lochav | 11 September 2026

GeoVax Labs (NASDAQ: GOVX) Appeals Nasdaq Delisting With October Hearing

GeoVax Labs, Inc. (NASDAQ: GOVX) will appeal its Nasdaq delisting determination at a Hearings Panel session scheduled for October 13, 2026.

Vinay Lochav | 11 September 2026

Gossamer Bio (NASDAQ: GOSS) Targets Nasdaq Bid-Price Compliance After 1-for-80 Split

Gossamer Bio, Inc. (NASDAQ: GOSS) completed a 1-for-80 reverse stock split, converting every 80 outstanding common shares into one share. The move is intended to help the stock meet Nasdaq’s $1.00 minimum closing bid requirement before the October 5 compliance date.

Vinay Lochav | 11 September 2026

IceCure Medical (NASDAQ: ICCM) Wins China Approval for ProSense

IceCure Medical Ltd. (NASDAQ: ICCM) can market its ProSense system in China after receiving approval from the National Medical Products Administration on September 10, 2026. The authorization covers the system and its associated cryoprobes under the approved registration.

Vinay Lochav | 11 September 2026

AtaiBeckley (NASDAQ: ATAI) Completes Lilly Merger for $6.75 Per Share

AtaiBeckley Inc. (NASDAQ: ATAI) completed its merger with Eli Lilly and Company (NYSE: LLY) on September 11, 2026, becoming aWholly Owned Subsidiaryof Lilly. Each eligible common share converted into $6.75 in cash plus one contingent value right that can pay up to $2.50 per …

Vinay Lochav | 11 September 2026

Axogen (NASDAQ: AXGN) Targets $200M BioCircuit Acquisition With Stock Sale

Axogen, Inc. (NASDAQ: AXGN) agreed to acquire BioCircuit Technologies for a base cash purchase price of $200.0 million. The transaction would make BioCircuit a wholly owned subsidiary, while Axogen intends to use substantially all net proceeds from a common-stock offering to fund the cash …

Vinay Lochav | 11 September 2026

BetterLife Pharma Receives $127,500 From Warrant Exercises (OTC: BETRF)

BetterLife Pharma Inc. (OTC: BETRF) appointed Charles Duncan, PhD, as a director and chair of its audit committee in August 2026. The appointment came with 500,000 stock options exercisable at $0.285 per share, alongside a further option grant carrying the same exercise price.

Vinay Lochav | 11 September 2026

BioCardia (NASDAQ: BCDA) Sets September 14 CardiAMP and Platform Presentation

BioCardia, Inc. (NASDAQ: BCDA) will present its CardiAMP program and related technology platforms at the H.C. Wainwright conference beginning September 14 in New York.

Vinay Lochav | 11 September 2026
Support

Hi! How can we help you today?

Loading…